Oncologic procedures amenable to fluorescence-guided surgery, Ann. Surg, 2016. ,
Image-guided cancer surgery using near-infrared fluorescence, Nat. Rev. Clin. Oncol, vol.10, pp.507-518, 2013. ,
Intraoperative molecular imaging: the surgical oncologist's north star, Ann. Surg, vol.266, pp.42-44, 2017. ,
Optical image-guided cancer surgery: challenges and limitations, Clin. Cancer Res, vol.19, pp.3745-3754, 2013. ,
Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging, J. Biomed. Opt, vol.21, 2016. ,
Fluorescence-guided surgery with live molecular navigation-a new cutting edge, Nat. Rev. Cancer, vol.13, pp.653-662, 2013. ,
Successful translation of fluorescence navigation during oncologic surgery: a consensus report, J. Nucl. Med, vol.57, pp.144-150, 2016. ,
Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation, Mol. Imaging, vol.9, pp.237-255, 2010. ,
Image guided tumor resection, Cancer J. Sudbury Mass, vol.21, p.206, 2015. ,
Fluorescence-guided surgery with live molecular navigation -a new cutting edge, Nat. Rev. Cancer, vol.13, pp.653-662, 2013. ,
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies, Ann. Surg, vol.243, pp.212-222, 2006. ,
Summary of current therapeutic options for peritoneal metastases from colorectal cancer, J. Surg. Oncol, vol.107, pp.566-573, 2013. ,
Selecting targets for tumor imaging: an overview of cancer-associated membrane proteins, Biomark. Cancer, vol.8, pp.119-133, 2016. ,
Use of Panitumumab-IRDye800 to image cutaneous head and neck Cancer in mice. otolaryngol-head neck surg off, J. Am. Acad. Otolaryngol.-Head Neck. Surg, 2013. ,
Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer, J. Surg. Res, vol.188, pp.119-128, 2014. ,
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies, J. Nucl. Med, vol.52, pp.1778-1785, 2011. ,
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting, Br. J. Cancer, vol.108, pp.662-667, 2013. ,
In search for optimal targets for intraoperative fluorescence imaging of peritoneal metastasis from colorectal cancer, Toxicology Reports, vol.6, pp.409-415, 2019. ,
, Biomark. Cancer, vol.9, 2017.
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review), Oncol. Rep, vol.39, pp.2455-2472, 2018. ,
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues, Semin. Cancer Biol, vol.9, pp.67-81, 1999. ,
Expression of cell adhesion molecules and prognosis in breast cancer, Br. J. Surg, vol.100, pp.252-260, 2013. ,
SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery, Surg. Oncol, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02371819
, Toxicol. Rep, vol.5, pp.196-206, 2018.
Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy, Cancer Res, vol.58, pp.1469-1477, 1998. ,
PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel, Comput. Methods Programs Biomed, vol.99, pp.306-314, 2010. ,
Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors, Curr. Opin. Immunol, vol.3, pp.685-693, 1991. ,
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy, J. Clin. Oncol, vol.24, pp.823-834, 2006. ,
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning, N. Engl. J. Med, vol.298, pp.1384-1386, 1978. ,
Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation, N. Engl. J. Med, vol.303, pp.5-10, 1980. ,
Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer-identification, prevention, and management, J. Support. Oncol, vol.5, pp.451-457, 2007. ,
Managing premedications and the risk for reactions to infusional monoclonal antibody therapy, Oncologist, vol.13, pp.725-732, 2008. ,
Adverse events to monoclonal antibodies used for cancer therapy: focus on hypersensitivity responses, Oncoimmunology, vol.2, p.26333, 2013. ,
Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study, Lancet Gastroenterol. Hepatol, pp.30395-30398, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02284980
Image-guided surgery in patients with pancreatic cancer: first results of a clinical trial using SGM-101, a novel carcinoembryonic antigen-targeting, near-infrared fluorescent agent, Ann. Surg. Oncol, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02289226
Beyond the margins: real-time detection of cancer using targeted fluorophores, Nat. Rev. Clin. Oncol, vol.14, pp.347-364, 2017. ,